39.5 F
Tuesday, February 20, 2024

FDA panel OKs Crestor cholesterol pill’s wider use

More by this author

Federal health advisers say expanded use of AstraZeneca’s cholesterol pill Crestor can patients with healthy cholesterol levels by preventing heart attack, stroke and death.

A Food and Drug Administration panel voted 12-4 with one abstention that Crestor’s benefits outweigh its risks in patients with normal cholesterol and no history of heart disease, setting the stage for a dramatic expansion of a drug that is already a blockbuster seller.

The FDA is not required to follow the group’s advice, though it usually does.

benefit A positive FDA ruling would give Crestor the broadest indication of any cholesterol drug in the U.S.

FDA’s panelist’s said the drug’s lifesaving potential outweighed side effects, including diabetes risk.

© 2009 Associated Press. Displayed by permission. All rights reserved.

- Advertisement -

Upcoming Online Townhalls

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected


Related articles

Popular articles

Español + Translate »
Skip to content